A cold chain break is a gap in the continuity of temperature control, a point where a product was not demonstrably held inside its required range, whether or not the temperature itself is known to have moved outside that range. This is a narrower point than it sounds: a break is about proof, not only about heat or cold.
A product can suffer an actual temperature excursion, a confirmed reading outside its band, without any break in monitoring, because the excursion was recorded the whole time. A product can also sit through a break, an hour on an unmonitored dock with no logger running, and come out the other side at a perfectly fine temperature. Both are real problems, and they are not the same problem.
Continuity is the thing being protected
The cold chain is judged on whether temperature control was continuous from origin to point of use, not only on whether the final reading looked acceptable. A break interrupts that continuity: a leg of the route where no record exists, where a device stopped logging, or where custody changed hands without anyone confirming the product stayed in range during the transfer.
This is why a break and an excursion get treated as related but distinct events. An excursion is a confirmed fact: the temperature moved outside the range, and there is a record proving it. A break is an absence: nobody can say what the temperature did, because nothing was watching.
An unmonitored leg is a break even if it stayed cold
A shipment moved for two hours by a courier who did not activate a logger, or held overnight in a facility with no temperature record for that period, has broken its chain of proof regardless of what the actual temperature happened to be during that time. The product may have stayed perfectly within range the whole time. Nobody can demonstrate that, and in a regulated cold chain, an undocumented gap is treated the same way as an unconfirmed one.
This is a source of real friction for logistics teams, because it means a product can be fully undamaged and still fail a compliance review, purely on the grounds that its record has a hole in it. The standard response is to quarantine the affected batch pending an investigation, exactly as it would for a confirmed excursion, until someone can establish whether the gap actually put the product at risk.
Detecting a break after the fact
Breaks surface during a record review, not usually in real time, because a break is defined by an absence of data rather than an alarm firing. Quality teams reconstruct a shipment's full route from its temperature data loggers, shipping documents and handoff records, and any stretch of the route without a matching data point gets flagged as a gap needing explanation.
Continuous monitoring, where a connected device reports without interruption rather than storing data for later download, closes off most of the gaps a courier or warehouse could otherwise leave unrecorded, because a missing signal itself becomes an alert rather than something discovered days later during a review.
Handoffs are the likeliest failure point
Handoffs are the most common source of a break: a change of carrier, a customs inspection that pulls a shipment out of its container, a transfer between a truck and a cold storage warehouse where nobody restarted the monitoring device. A steady, single-carrier leg with one continuous logger running is far less likely to produce a gap than a multi-party lane with several changes of custody.
Equipment failure adds another path: a logger with a dead battery, a device that was never actually turned on before the shipment left, or a monitoring system that lost connectivity mid-transit all produce the same result on review, a stretch of the route with no usable record, whatever the true temperature was during that stretch.
The response once a gap surfaces
Quality assurance and regulatory affairs staff investigate a suspected break, typically drawing on the same shelf-life and stability data used to judge a confirmed excursion, since the underlying question, is this product still safe to use, is identical even when the evidence is an absence rather than a reading. Pharmaceutical manufacturers, blood services and vaccine programs all maintain a defined procedure for exactly this scenario.
The safest response to an undocumented gap is usually the same one used for a documented failure: hold the batch, document the gap, and let a quality review decide the product's fate rather than assuming it is fine because nothing measured proved otherwise.